RU2019109011A3 - - Google Patents

Download PDF

Info

Publication number
RU2019109011A3
RU2019109011A3 RU2019109011A RU2019109011A RU2019109011A3 RU 2019109011 A3 RU2019109011 A3 RU 2019109011A3 RU 2019109011 A RU2019109011 A RU 2019109011A RU 2019109011 A RU2019109011 A RU 2019109011A RU 2019109011 A3 RU2019109011 A3 RU 2019109011A3
Authority
RU
Russia
Application number
RU2019109011A
Other languages
Russian (ru)
Other versions
RU2019109011A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019109011A publication Critical patent/RU2019109011A/ru
Publication of RU2019109011A3 publication Critical patent/RU2019109011A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
RU2019109011A 2016-09-01 2017-08-31 Композиции и способы с использованием фармакогеномного маркера RU2019109011A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662382734P 2016-09-01 2016-09-01
US62/382,734 2016-09-01
US201662414601P 2016-10-28 2016-10-28
US62/414,601 2016-10-28
PCT/US2017/049747 WO2018045240A1 (en) 2016-09-01 2017-08-31 Methods and composition for the prediction of the activity of enzastaurin

Publications (2)

Publication Number Publication Date
RU2019109011A RU2019109011A (ru) 2020-10-05
RU2019109011A3 true RU2019109011A3 (cg-RX-API-DMAC7.html) 2021-01-22

Family

ID=59923555

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019109011A RU2019109011A (ru) 2016-09-01 2017-08-31 Композиции и способы с использованием фармакогеномного маркера

Country Status (15)

Country Link
US (2) US11421280B2 (cg-RX-API-DMAC7.html)
EP (1) EP3507384B1 (cg-RX-API-DMAC7.html)
JP (3) JP7197915B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190046935A (cg-RX-API-DMAC7.html)
CN (1) CN109952383B (cg-RX-API-DMAC7.html)
AU (1) AU2017318669B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019003951A2 (cg-RX-API-DMAC7.html)
CA (1) CA3035386A1 (cg-RX-API-DMAC7.html)
JO (1) JOP20190025A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019002377A (cg-RX-API-DMAC7.html)
PH (1) PH12019500422A1 (cg-RX-API-DMAC7.html)
RU (1) RU2019109011A (cg-RX-API-DMAC7.html)
SG (2) SG10201912134TA (cg-RX-API-DMAC7.html)
TW (2) TWI771317B (cg-RX-API-DMAC7.html)
WO (1) WO2018045240A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190025A1 (ar) 2016-09-01 2019-02-19 Denovo Biopharma Llc طرق وتركيبة لتوقع نشاط إنزاستورين
CN110496223B (zh) * 2018-05-17 2021-09-10 复旦大学附属肿瘤医院 一种治疗非霍奇金氏淋巴瘤的药物组合物
JP2022500408A (ja) * 2018-09-12 2022-01-04 デノボ バイオファーマ エルエルシー エンザスタウリンとbtkの阻害剤との組合せおよびその使用
CN111549033B (zh) * 2020-06-11 2021-02-12 南京市江宁医院 慢病毒感染人表皮角质细胞株及其构建方法和应用
US11227690B1 (en) * 2020-09-14 2022-01-18 Opendna Ltd. Machine learning prediction of therapy response
CN117642827A (zh) * 2021-07-23 2024-03-01 高雄医学大学 用于评估二代荷尔蒙药物治疗前列腺癌疗效的临床治疗药物预测和推荐系统及方法
US20230131677A1 (en) * 2021-10-21 2023-04-27 Toyota Research Institute, Inc. Systems and methods for predicting the effect of an intervention via machine learning
CN118339312A (zh) * 2021-11-23 2024-07-12 索元生物医药(美国)有限公司 用于评估多核苷酸递送和癌疗法之功效的组合物和方法
US12474842B2 (en) * 2021-12-13 2025-11-18 Google Llc Optimizing data placement based on data temperature and lifetime prediction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1449529B1 (en) 1993-12-23 2010-01-27 Eli Lilly And Company Protein Kinase C Inhibitors
JP2004512029A (ja) 2000-08-16 2004-04-22 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物
US20040072217A1 (en) 2002-06-17 2004-04-15 Affymetrix, Inc. Methods of analysis of linkage disequilibrium
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
US20080299125A1 (en) 2006-06-05 2008-12-04 Perlegen Sciences, Inc. Genetic basis of treatment response in depression patients
MX2013008846A (es) * 2011-01-31 2014-02-11 Denovo Biomarkers Inc Metodo para descubrir biomarcadores farmacogenomicos.
US10202652B2 (en) 2011-06-08 2019-02-12 Denovo Biopharma (Hangzhou) Ltd. Co. Methods and compositions of predicting activity of retinoid X receptor modulator
JOP20190025A1 (ar) 2016-09-01 2019-02-19 Denovo Biopharma Llc طرق وتركيبة لتوقع نشاط إنزاستورين

Also Published As

Publication number Publication date
TWI771317B (zh) 2022-07-21
TW201812125A (zh) 2018-04-01
EP3507384B1 (en) 2023-08-30
EP3507384A1 (en) 2019-07-10
TW202313973A (zh) 2023-04-01
BR112019003951A2 (pt) 2019-06-25
JOP20190025A1 (ar) 2019-02-19
SG10201912134TA (en) 2020-02-27
WO2018045240A1 (en) 2018-03-08
US20190233902A1 (en) 2019-08-01
JP7197915B2 (ja) 2022-12-28
AU2017318669A1 (en) 2019-03-07
KR20190046935A (ko) 2019-05-07
CA3035386A1 (en) 2018-03-08
JP2020188816A (ja) 2020-11-26
US20230074781A1 (en) 2023-03-09
US11421280B2 (en) 2022-08-23
RU2019109011A (ru) 2020-10-05
MX2019002377A (es) 2019-09-05
PH12019500422A1 (en) 2019-05-27
CN109952383B (zh) 2024-01-05
JP2019528705A (ja) 2019-10-17
AU2017318669B2 (en) 2023-04-20
SG11201901762WA (en) 2019-03-28
CN109952383A (zh) 2019-06-28
JP2022173308A (ja) 2022-11-18

Similar Documents

Publication Publication Date Title
BR112019009201A2 (cg-RX-API-DMAC7.html)
BR112019002665A2 (cg-RX-API-DMAC7.html)
BR112018004986A2 (cg-RX-API-DMAC7.html)
BR112019001429A2 (cg-RX-API-DMAC7.html)
BR112019000402A2 (cg-RX-API-DMAC7.html)
BR212018070320U2 (cg-RX-API-DMAC7.html)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019006736A2 (cg-RX-API-DMAC7.html)
CN303647635S (zh) 庭审直播主机(高清环通)
CN303640764S (zh) 北斗通讯定位终端一体机
CN303626936S (zh) 铝塑盖(a款)
CN303616691S (zh) 包装盒(滇紫草)
CN303639659S (zh) 模块化设备外壳平台(连线单元模块)
CN303625898S (zh) 茶壶(侧壶系列)
CN303609751S (zh) 儿童座椅
CN303537476S (zh) 飞碟吊椅
CN303536597S (zh) C型伞手柄
CN303611290S (zh) 包装袋(红豆情)
CN303537535S (zh) 车家床(四六分圆拉床半围)
CN303573037S (zh) 包装卡纸(压蒜器-日美厨具)
CN303536111S (zh) 眼罩(条纹)
CN303536113S (zh) 眼罩